decisionhealth Newsletters, Part B News - 2016 Issue 6 (June)
JW modifier changes to standardize drug wastage billing postponed to Jan. 1
Subscribe or sign in to view the full article.
Article Overview
This article covers a CMS postponement related to drug wastage billing policy and the JW modifier, along with related Medicare guidance for reporting discarded drug amounts. It is relevant to billing staff, coders, compliance teams, and providers who handle Part B drug claims. The article also touches on contractor variability, CAP drug exclusions, and documentation elements tied to wastage reporting.
Why This Topic Matters
Drug wastage billing rules can affect claim accuracy, compliance, and payment timing. A postponed implementation date changes when providers must align processes, so organizations need to understand the current expectations and related documentation requirements.
What You Will Learn
- How CMS timing changes can affect drug wastage billing policy
- The role of the JW modifier in reporting discarded drug amounts
- Which Medicare documentation elements are discussed for wastage reporting
- How contractor guidance and implementation dates factor into claim preparation
Who Should Read This
- Medical coders
- Billing staff
- Compliance professionals
- Physician practices
- Hospital outpatient departments
- Medicare providers and suppliers
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com